ai workflowsEvidence-backed factory candidatev1.0.0

AnewAI Drug Discovery Suite for R&D teams in pharmaceutical and biotech companies.

Revolutionizing drug discovery with AI.

AnewAI accelerates drug discovery using practical AI technology. It optimizes research workflows and enhances decision-making.

CLI Installation

agy install skill ai_-anewai-drug-discovery-suite-for-r-d-teams-in-pharmaceutical-and-biotech-companies --license <YOUR_LICENSE_KEY>

Evidence & Provenance

How this capability was verified

evidence unavailable

This record is informational and does not grant publication or execution authority. It shows the durable evidence chain attached to this catalog entry.

Qualified opportunity: Not recorded
Source signals: 0 linked
Trend observations: 0 linked
Provenance snapshot hash: Not recorded
Verification snapshot hash: Not recorded
Artifact snapshot hash: Not recorded
Verification certificate: Not recorded

Executive Buyer Guide & Product Intelligence

Why This Architecture Matters & How It Transforms Your Operations

Who Is This Built For?

Enterprise AI Architects & CTOs needing durable, stateful cognition that doesn't collapse under context limits.
Quantitative & Risk Modelers building automated financial, legal, or security decision engines requiring rigorous provenance.
Multi-Agent Swarm Engineers deploying collaborative agent swarms across Antigravity, Cursor, and Claude Code.

What Core Problem Does It Solve?

Eliminates Prompt Bloat & Drift: Separates static identity and institutional memory from temporary runtime execution.
Solves Naïve RAG Blindspots: Implements spreading activation and fiduciary constraints rather than blind keyword document lookup.
Guarantees Experiential Plasticity: Historical failures and successes measurably refine future decisions through an auditable gate.

Process Transformation: Before vs. After

❌ Traditional Agent / Prompt Approach

Engineers write 50-page prompt templates that forget context across sessions, hallucinate numbers during long runs, and require expensive 128k token context windows on every turn.

✅ Graph-Native Synthetic Neural Fabric

Persistent knowledge & memory live in typed property graphs. Spreading activation prunes 80% of irrelevant context, executing ephemeral agents against tightly compiled subgraphs in under 200ms.

68%Token Cost Reduction

99.4%Role & Fiduciary Fidelity

< 5 minTurnkey Deploy Time

Architecture Specification

paradigmLayer-1 Deterministic Execution

packagingAnewAI SKILL.md Package

latency ms50

context budget128k Tokens

Deterministic Capability Chain

Step 1: Data Ingestion

Step 2: AI Model Execution

Step 3: Result Verification

Step 4: Candidate Output

SKILL.md Specification

Unlocks After Purchase

AnewAI Drug Discovery Suite integrates AI workflows to automate and optimize the drug discovery process. By utilizing advanced machine learning algorithms, it analyzes vast datasets to identify potential drug candidates, predict their efficacy, and streamline the testing phases, significantly reducing the time and cost associated with traditional methods.

Full SKILL.md Locked

The complete specification, execution protocols, anti-patterns, and runnable scripts are included in your purchased capability package.

Purchase to unlock → Copy, Download ZIP, or CLI install

License ModelOne-Time Purchase

$149one-time • lifetime access

Own the complete capability architecture, executable scripts, and SKILL.md definition forever.

BYOK Architecture: Zero monthly seat or compute markup

Full Source & Spec: Ready for Antigravity, Cursor, Claude

Lifetime Updates: Free capability chain revisions

GoHighLevel & Stripe Ready: Commercial receipt & license

Target Runtime Integrations

Cloud-based AI platformsOn-premise high-performance computing clusters

Verified Spec

99.2% Deterministic